Else Nutrition Holdings Inc.: Else Nutrition Commends HHS & FDA's Operation Stork Speed on Expanding Infant Formula Options
HHS/FDA Announcement Bolsters Else Nutrition's Momentum in Bringing its Infant Formula to Market in the United States VANCOUVER, BC, March 20, 2025 /PRNewswire/ ...
Abeona Therapeutics Inc.: Abeona Therapeutics Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
FDA priority review of pz-cel Biologics License Application (BLA) progressing with Prescription Drug User Fee Act (PDUFA) target action date of April 29, 2025 Launch preparations on track toward goal ...